AT7867 Catalog No.:M10900-2 are expected to induce natriuretic

are expected to induce natriuretic and diuretic effects

InChiKey: FKUOVQVMCOPBJS-XERRXZQWSA-N

1 100 PMID: 30271980

Smiles: CC(C)CC1=CC=C(C=C1)[C@@H](C)C(=O)NS(C)(=O)=O

CEP-37440 is an orally available dual kinase inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) and focal adhesion kinase (FAK)

AT7867 Catalog No.:M10900-2 are expected to induce natriureticAT7867 is a novel and potent inhibitor of both AKT and the downstream kinase p70 S6 kinase (p70S6K) and also of protein kinase A. This ATP competitive small molecule potently inhibits both AKT and p70S6K activity at the cellular level, as measured by inhibition of GSK3beta and S6 ribosomal protein phosphorylation, and also causes growth inhibition in a range of human cancer cell lines as a single agent. Product information CAS Number: 857531 00 1